Picture of Esken logo

ESKN Esken News Story

0.000.00%
gb flag iconLast trade - 00:00
IndustrialsHighly SpeculativeMicro Cap

REG - Esken Limited - Results of AGM

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230830:nRSd8432Ka&default-theme=true

RNS Number : 8432K  Esken Limited  30 August 2023

30 August 2023

ESKEN LIMITED

("Esken" or "the Group")

 

Result of AGM

 

Esken, the Aviation and Renewables group, announces the result of voting on
the resolutions at its Annual General Meeting, held at 10.00 a.m. on 30 August
2023.

 

Resolutions 1 to 14 in the Notice of Annual General Meeting were passed by the
required majority by means of a poll. The results of the poll on each
resolution are set out below.

 

                                                                                For                  Against              Total votes cast  Votes withheld
 Resolution                                                                     No. of votes  %      No. of votes  %      No. of votes      No. of votes
 1.  Receive the 2023 Annual Accounts, Directors' Report and Auditor's Report   277,013,895   99.75  692,088       0.25   277,705,983       314,851
 2.  Re-elect David Shearer as a Director                                       274,678,598   98.99  2,805,886     1.01   277,484,484       536,350
 3.  Re-elect Nick Dilworth as a Director                                       276,537,150   99.66  948,948       0.34   277,486,098       534,736
 4.  Re-elect Ginny Pulbrook as a Director                                      276,597,592   99.68  889,142       0.32   277,486,734       534,100
 5.  Re-elect David Blackwood as a Director                                     276,601,093   99.68  885,641       0.32   277,486,734       534,100
 6.  Re-elect Clive Condie as a Director                                        276,600,631   99.68  886,103       0.32   277,486,734       534,100
 7.  Re-appoint Mazars LLP as Auditors                                          276,871,477   99.70  836,159       0.30   277,707,636       313,198
 8.  Authorise the Directors to determine the Auditors' remuneration            276,707,018   99.69  849,871       0.31   277,556,889       463,945
 9.  Approve the Directors' Remuneration Report                                 276,385,208   99.58  1,163,361     0.42   277,548,569       472,265
 10. Approve the Directors' Remuneration Policy                                 275,472,957   99.25  2,075,847     0.75   277,548,804       472,030
 11. Authorise the issuance of shares                                           275,666,731   99.27  2,034,857     0.73   277,701,588       319,246
 12. Disapply pre- emption rights                                               242,874,651   87.47  34,792,513    12.53  277,667,164       353,670
 13. Additional disapplication of pre-emption rights                            241,890,132   87.16  35,646,994    12.84  277,537,126       483,708
 14. Authorise the Company to make market acquisitions of its ordinary shares   275,786,195   99.30  1,931,656     0.70   277,717,851       302,983

 

The number of ordinary shares in issue on 30 August 2023 was 1,025,336,741. A
vote withheld is not a vote in law and is not counted in the calculation of
the proportion of votes 'For' or 'Against' a resolution.

 

A copy of resolutions 11 to 14 (being the special business of the Annual
General Meeting, as set out in the notice of the Annual General Meeting)
passed, will shortly be submitted to the National Storage Mechanism and will
be available at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

 

Enquiries:

 

Esken Limited C/O Teneo

Adam Davidson, General Counsel & Company Secretary

 

Tulchan Communications

Olivia Peters / Giles Kendrick

+44 20 7353 4200

esken@tulchangroup.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGWPUUURUPWGWU

Recent news on Esken

See all news